Showing results (1-10 of 104) with videos related to
Sort By:
Pageof 11
Diagnostic Immunology|January 1, 1985
A new and rapid quantitative assay for complement activation: an ELISA for C3dB R Adelsberg, L D Kerr, H SpieraThe Journal of Rheumatology|April 1, 1986
Complement activation in systemic lupus erythematosus: a marker of inflammationL D Kerr, B R Adelsberg, H SpieraArthritis and Rheumatism|November 1, 1989
Factor B activation products in patients with systemic lupus erythematosus. A marker of severe disease activityL D Kerr, B R Adelsberg, P Schulman, et al.Clinical Cardiology|December 1, 1993
Myocarditis as a complication in scleroderma patients with myositisL D Kerr, H SpieraThe Journal of Rheumatology|February 1, 1992
Scleroderma in association with the use of bleomycin: a report of 3 casesL D Kerr, H SpieraThe Journal of Rheumatology|June 1, 1993
Scleroderma following silicone implantation: a cumulative experience of 11 casesH Spiera, L D KerrThe Journal of Rheumatology|November 1, 1991
The coexistence of active classic rheumatoid arthritis and AIDSL D Kerr, H SpieraArchives of Internal Medicine|November 1, 1991
Clinical analysis of isolated angiitis of the central nervous system. A report of 11 casesR Crane, L D Kerr, H SpieraThe Journal of Rheumatology|November 1, 1991
A reexamination of the relationship between myositis and malignancyP Schulman, L D Kerr, H SpieraThe Journal of Rheumatology|May 1, 1992
The absence of factor B activation products in sclerodermaJ Valeriano-Marcet, L D Kerr, H SpieraPageof 11